Strong Fourth Quarter & Yearly Results - Research Report on Neogen

Jul 27, 2015, 09:30 ET from www.aciassociation.com

NEW YORK, July 27, 2015 /PRNewswire/ --

ACI Association has initiated research coverage on Neogen Corporation (NASDAQ: NEOG). Select highlights from the internally released reports are being made available to the general public (included below), with access to the entirety of the research available to new members.

Today, membership is open to readers on a complementary basis at the following URL: http://www.aciassociation.com/?c=NEOG

Highlights from our FCX Report include:

  • Q4 FY 2015 Revenues & EPS Exceeds Consensus Estimates - On July 21, Neogen Corporation released results for the fourth quarter and full year fiscal 2015. The Company generated total revenue of $78.6 million, reflecting an increase of 17% from $67.3 million in Q4 FY 2014. For fiscal 2015, revenue increased 14.4% YoY to $283.1 million. As per Zacks, the Company's Q4 FY 2015 revenues outpaced its consensus mark of $74 million. Net income attributable to Neogen in Q4 FY2015 amounted to $9.4 million or $0.25 per diluted shares, higher than $7.5 million or $0.20 per diluted shares in previous year quarter. Meanwhile, net income attributable to the Company in FY 2015 was $33.5 million or $0.90 per diluted shares, higher than $28.2 million or $0.76 per diluted shares in FY 2014. As per a report by RTT News, analysts polled by Thomson Reuters expected the company to earn $0.24 per share in Q4 FY 2015. As per the Company, revenues and net income for Q4 FY 2015 and FY 2015 established new all-time highs.
  • Improved Operating Performance - The Company's gross profit during Q4 FY 2015 stood at $37.7 million, compared to $32.0 million in prior year quarter. Consequently, gross margin for the quarter was 48.0%, as compared to 47.6% in Q4 FY 2014. Meanwhile, FY 2015 gross profit came in at $139.7 million or 49.3% of revenue, compared to $122.6 million or 49.6% of revenue in the prior year. Additionally, operating income grew from $11.0 million in Q4 FY 2014 to $14.6 million in the reported period.
  • Segment Performance Review - The Company's food safety segment generated revenue of $35.6 million in Q4 FY 2015, compared to $29.9 million in prior year period. For fiscal 2015, food safety segment's revenue grew by 13.1% YoY to $131.5 million. In addition, overall organic growth for the food safety segment was 10% for the year. The Company informed that sales of its general microbiology products improved by 40% in 2015, supported by the October 1, 2014 acquisition of BioLumix®. Meanwhile, the animal safety segment of the Company contributed $43.0 million to the total revenue of Q4 FY 2015. In addition, for fiscal 2015, the segment recorded an increase of 16% in the revenues, amounting to $151.6 million from $131.1 million in fiscal 2014. Improved yearly revenue growth of the segment was aided by three acquisitions made by the Company in 2014 fiscal year.

To find out how this influences our rating on Neogen Corporation read the full report in its entirety here: http://www.aciassociation.com/?c=NEOG

About ACI Association: 

Active Charter Investors Association ("ACI Association") produces regular sponsored and non-sponsored reports, articles, stock market blogs, and popular investment newsletters covering equities listed on NYSE and NASDAQ and micro-cap stocks. ACI Association has two distinct and independent departments. One department produces non-sponsored analyst certified content generally in the form of press releases, articles and reports covering equities listed on NYSE and NASDAQ and the other produces sponsored content (in most cases not reviewed by a registered analyst), which typically consists of compensated investment newsletters, articles and reports covering listed stocks and micro-caps. Such sponsored content is outside the scope of procedures detailed below.

ACI Association has not been compensated; directly or indirectly; for producing or publishing this document.

PRESS RELEASE PROCEDURES:  

The non-sponsored content contained herein has been prepared by a writer (the "Author") and is fact checked and reviewed by a third party research service company (the "Reviewer"). Rohit Tuli, a CFA® charter holder (the "CFA®"), provides necessary guidance in preparing the document templates. The Reviewer has reviewed and revised the content, as necessary, based on sound investment judgment and publicly available information which is believed to be reliable. The Reviewer and the CFA® have not performed any independent investigations or forensic audits to validate the information herein. Unless otherwise noted, any content outside of this document has no association with the Author, the Reviewer, or the CFA® (collectively referred to as the "Production Team") in any way. The Production Team is compensated on a fixed monthly basis and do not hold any positions of interest in any of the securities mentioned herein.

NO WARRANTY 

ACI Association, the Author, the Reviewer and the CFA® (collectively referred to as the "Publishers") are not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by the Publishers whatsoever for any direct, indirect or consequential loss arising from the use of this document. The Publishers expressly disclaim any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Additionally, the Publishers do not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

NOT AN OFFERING 

This document is not intended as an offering, recommendation, or a solicitation of an offer to buy or sell the securities mentioned or discussed, and is to be used for informational purposes only. Please read all associated disclosures and disclaimers in full before investing. Neither ACI Association nor any party affiliated with us is a registered investment adviser or broker-dealer with any agency or in any jurisdiction whatsoever. To download our report(s), read our disclosures, or for more information, visit http://www.aciassociation.com/.

RESTRICTIONS 

ACI Association is not available to residents of Belarus, Cuba, Canada, Iran, North Korea, Sudan, Syria or Somalia. Do not send email to robottrap (at) aciassociation.com.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

SOURCE www.aciassociation.com